Literature DB >> 9472690

Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer.

J P Gil1, M C Lechner.   

Abstract

Here we report that colorectal cancer patients show a markedly higher frequency (3-fold) of wild-type NAT2*4 allele homozygotes than the control population. However, a marked difference in NAT2*4/NAT2*4 genotype frequency associated with the patients gender was observed pointing to a male-specific effect of this genotype as a risk factor in colon cancer. The arylamine-N-acetyltransferase (E.C. 2.3.1.5.) NAT2, a phase II detoxification enzyme, has been implicated in procarcinogen activation, namely from food contained arylamines, cigarette smoking, as well as environmental amines of various types. NAT2 is encoded by a polymorphic gene presenting several allelic variants encoding partially inactive enzymes expressed in human liver and colon. Epidemiological studies based on phenotype determination have long indicated the importance of the NAT2 active phenotype as a susceptibility factor in colorectal cancer. In the present study we investigated the NAT2 allelic frequencies and genotype distribution in a group of 114 unrelated colorectal cancer patients, in parallel with 201 healthy Portuguese subjects. We first demonstrate that the frequency of the wild-type NAT2*4 allele in the Portuguese sample population (23.4%) does not significantly differ from the values described for other Europeans. Besides the 3-fold higher frequency of NAT2*4 homozygotes found in colorectal cancer subjects, the NAT2*4/NAT2*5A compound genotype, known to determine a faster acetylator phenotype than other heterozygotic combinations, also increased by the same order of magnitude. These two genotypes represent 32% of the patients population versus 11% of the healthy controls. Taken together, our results strongly indicate that NAT2 genotype, particularly NAT2*4 allele zygosity, constitutes an individual susceptibility trait associated with sporadic colorectal cancer development, probably due to the local dietary habits in Portugal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472690     DOI: 10.1093/carcin/19.1.37

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

2.  N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer.

Authors:  Steffen Pistorius; Heike Goergens; Christoph Engel; Jens Plaschke; Stefan Krueger; Ruth Hoehl; Hans-Detlev Saeger; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2006-08-02       Impact factor: 2.571

3.  Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study.

Authors:  Lesley M Butler; Robert C Millikan; Rashmi Sinha; Temitope O Keku; Scott Winkel; Brent Harlan; Allison Eaton; Marilie D Gammon; Robert S Sandler
Journal:  Mutat Res       Date:  2007-10-13       Impact factor: 2.433

4.  N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.

Authors:  Jinxin Liu; Dapeng Ding; Xiaoxue Wang; Yizhi Chen; Rong Li; Ying Zhang; Rongcheng Luo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

5.  Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.

Authors:  Lou qian Zhang; Jian nong Zhou; Jun Wang; Guo dong Liang; Jing ying Li; Yi dan Zhu; Yun tao Su
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 6.  The role of genetic polymorphisms in environmental health.

Authors:  Samir N Kelada; David L Eaton; Sophia S Wang; Nathaniel R Rothman; Muin J Khoury
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

7.  Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.

Authors:  Daya S L Srivastava; Rama D Mittal
Journal:  BMC Urol       Date:  2005-08-06       Impact factor: 2.264

8.  N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.

Authors:  Juergen Borlak; Stella Marie Reamon-Buettner
Journal:  BMC Med Genet       Date:  2006-07-09       Impact factor: 2.103

9.  Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.

Authors:  Yazun Bashir Jarrar; Ayat Ahmed Balasmeh; Wassan Jarrar
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.